Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-053909
Filing Date
2023-02-28
Accepted
2023-02-28 16:18:14
Documents
7
Period of Report
2023-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d394158d6k.htm 6-K 10001
2 EX-99.1 d394158dex991.htm EX-99.1 382796
3 EX-99.2 d394158dex992.htm EX-99.2 8071
4 EX-99.3 d394158dex993.htm EX-99.3 4046
5 GRAPHIC g394158g00m01.jpg GRAPHIC 28000
6 GRAPHIC g394158g04h85.jpg GRAPHIC 1885
7 GRAPHIC g394158g87u07.jpg GRAPHIC 2812
  Complete submission text file 0001193125-23-053909.txt   451519
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 23685638
SIC: 2834 Pharmaceutical Preparations